Latest News and Press Releases
Want to stay updated on the latest news?
-
Tuebingen, Germany and Houston, Texas, Aug. 18, 2020 (GLOBE NEWSWIRE) -- First patient has been treated in Germany in Immatics’ ACTengine® IMA202-101 trialGerman regulatory agency,...
-
Tübingen, Deutschland und Houston, Texas, Aug. 18, 2020 (GLOBE NEWSWIRE) -- Der erste Patient in Deutschland wurde im Rahmen der Immatics‘ ACTengine® IMA202-101 Studie behandeltDie deutsche...
-
Houston, Texas, Aug. 06, 2020 (GLOBE NEWSWIRE) -- Extension of collaboration between UTHealth and Immatics until end of 2024 providing Immatics exclusive access to state-of-the art cGMP...
-
Houston, Texas and Tuebingen, Germany, July 09, 2020 (GLOBE NEWSWIRE) -- Houston, Texas and Tuebingen, Germany, July 9, 2020 – Immatics N.V. (NASDAQ: IMTX, “Immatics”), a clinical-stage...
-
Houston, Texas and Tuebingen, Germany, July 02, 2020 (GLOBE NEWSWIRE) -- The business combination transaction with Arya Sciences Acquisition Corporation, a special purpose acquisition company...
-
Houston, Texas und Tübingen, Deutschland, July 02, 2020 (GLOBE NEWSWIRE) -- Die Fusion mit Arya Sciences Acquisition Corporation, eine von Perceptive Advisors gegründete „SPAC“, wurde am 1....